Buprenorphine Testing in Opioid Addiction

The opioid epidemic is well-known around the world. From heroin overdoses to teens addicted to pain pills and a neighbor in recovery taking buprenorphine, opioids are everywhere. Education and awareness are the first steps in addressing this public-health crisis.

Buprenorphine is used in medically assisted treatment in the fight against heroin addiction, so it’s crucial to test patients to ensure compliance with their treatment plan. However, buprenorphine can also be abused; therefore, screening for buprenorphine is imperative in workplaces, prisons, parole offices, and emergency departments. This webinar will discuss the history of opioids, the biology of opioid addiction, why buprenorphine should be tested, and how Siemens Healthineers can help you grow your drugs-of-abuse testing offering.
 

Speaker:Roma Levy
Clinical and Scientific Writer
Global Assay Marketing
Siemens Healthineers

Register today!

After viewing this presentation, you will be able to:

  • Describe the magnitude of the opioid epidemic and illustrate why it is important to test for buprenorphine.
  • Describe the performance characteristics of the Siemens Healthineers Syva® Emit® II Plus Buprenorphine Assay.
  • Recognize the benefits of migrating to the Emit Buprenorphine assay.

Siemens Healthineers continues to provide educational opportunities on key topics important to laboratorians. We invite you to participate in other Siemens Healthineers webinars. Log on and learn!